The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: A Southwest Oncology Group Study
James K. Weick, John J. Crowley, Mohamed A. Hussein, Dennis F. Moore, Bart Barlogie
Research output: Contribution to journal › Article › peer-review
12Scopus
citations
Fingerprint
Dive into the research topics of 'The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: A Southwest Oncology Group Study'. Together they form a unique fingerprint.